Biological Dose Optimization for Particle Arc Therapy Using Helium and Carbon Ions

Stewart Mein1, Thomas Tessonnier2, Benedikt Kopp1

  • 1Clinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Heidelberg Faculty of Medicine (MFHD) and Heidelberg University Hospital (UKHD), Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany; German Cancer Consortium (DKTK) Core-Center Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, Germany; Clinical Cooperation Unit Radiation Oncology, Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Oncology (NCRO), Heidelberg University and German Cancer Research Center (DKFZ), Heidelberg, Germany.

Summary

Spot-scanning hadron arc (SHArc) therapy optimizes particle arc therapy for helium and carbon ions, improving target dose and sparing normal tissues. This advanced technique shows promise for clinical translation in cancer treatment.